Indeed, pro-inflammatory cytokines such as IL-1β, IL-6, IL-12, IL-17A, IL-23, IFN-γ and TNFα observed in GCA patients represent potential targets for the treatment of this intriguing disease [2,31] (Figure 1), and are overproduced. The gene discussed is IL6; the disease is temporal arteritis.